Interpace Biosciences, Inc. (IDXG)
1.763
+0.02
(+1.32%)
USD |
OTCM |
Jun 10, 16:00
Interpace Biosciences Market Cap : 48.84M for June 10, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| June 10, 2026 | 48.84M |
| June 09, 2026 | 48.20M |
| June 08, 2026 | 46.54M |
| June 05, 2026 | 46.26M |
| June 04, 2026 | 49.58M |
| June 03, 2026 | 48.48M |
| June 02, 2026 | 48.75M |
| June 01, 2026 | 47.65M |
| May 29, 2026 | 47.09M |
| May 28, 2026 | 49.86M |
| May 27, 2026 | 49.86M |
| May 26, 2026 | 49.86M |
| May 22, 2026 | 50.42M |
| May 21, 2026 | 49.86M |
| May 20, 2026 | 49.86M |
| May 19, 2026 | 49.86M |
| May 18, 2026 | 48.48M |
| May 15, 2026 | 49.32M |
| May 14, 2026 | 49.86M |
| May 13, 2026 | 52.63M |
| May 12, 2026 | 55.40M |
| May 11, 2026 | 57.37M |
| May 08, 2026 | 54.02M |
| May 07, 2026 | 55.40M |
| May 06, 2026 | 58.45M |
| Date | Value |
|---|---|
| May 05, 2026 | 55.62M |
| May 04, 2026 | 55.40M |
| May 01, 2026 | 58.73M |
| April 30, 2026 | 54.85M |
| April 29, 2026 | 55.12M |
| April 28, 2026 | 53.57M |
| April 27, 2026 | 53.57M |
| April 24, 2026 | 54.71M |
| April 23, 2026 | 56.04M |
| April 22, 2026 | 55.33M |
| April 21, 2026 | 55.40M |
| April 20, 2026 | 56.68M |
| April 17, 2026 | 59.14M |
| April 16, 2026 | 60.94M |
| April 15, 2026 | 60.94M |
| April 14, 2026 | 60.94M |
| April 13, 2026 | 60.94M |
| April 10, 2026 | 63.71M |
| April 09, 2026 | 63.71M |
| April 08, 2026 | 54.91M |
| April 07, 2026 | 55.26M |
| April 06, 2026 | 54.57M |
| April 02, 2026 | 54.23M |
| April 01, 2026 | 51.25M |
| March 31, 2026 | 52.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Medical Marijuana, Inc. | 2.410M |
| Acro Biomedical Co. Ltd. | 1.561M |
| Stella Diagnostics, Inc. | 3.112M |
| Wellgistics Health, Inc. | 8.931M |
| IDEXX Laboratories, Inc. | 44.13B |
Market Cap Related Metrics
| PE Ratio | 2.408 |
| PS Ratio | 1.064 |
| Price to Book Value | 2.116 |
| Price to Free Cash Flow | 8.804 |
| Price | 1.763 |
| Earnings Yield | 41.52% |
| Operating PE Ratio | 11.42 |
| Normalized PE Ratio | 2.422 |